Takayuki Morita, the CEO of NEC Corporation, discusses what the second Trump presidency will mean for technological ...

One of these is currently in clinical trials for two solid tumors, and another is poised to enter human trials in the near future, making NEC the first Japanese company to run clinical trials in ...

Biomy has developed its DeepPathFinder digital pathology platform to analyze images to classify cell and tissue types in specific regions.

An announcement from NEC ( ($JP:6701) ) is now available. NEC Corporation has successfully completed a tender offer to acquire shares of NEC ...

TOKYO -- Japan's NTT Docomo and NEC will develop a high-speed communications ... has signed a memorandum of understanding with Indonesian communications company Solusi Sinergi Digital, better ...

By advancing next-generation AI/DL-based pathology analysis platforms and promoting the use of the newly developed ...

Japanese companies’ total investment in Sakana AI is estimated at around 10 billion yen. The new investors include NEC Corp., Fujitsu Ltd., KDDI Corp. and Itochu Group. The latest round of fund ...